OncoSec Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 233.2%.

Top 22 shareholders own 30.06% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.8%	Grand Pharmaceutical Group Limited	763,549	US$103.1k	0%	no data
5.97%	The Lind Partners, LLC	355,733	US$48.0k	0%	0.31%
4.31%	SZOP Multistrat Management LLC	257,118	US$34.7k	0%	no data
2.56%	Sirtex Medical US Holdings, Inc.	152,711	US$20.6k	0%	no data
1.77%	FNY Investment Advisers, LLC	105,690	US$14.3k	0%	0.04%
0.96%	The Vanguard Group, Inc.	57,488	US$7.8k	76.3%	no data
0.42%	State Street Global Advisors, Inc.	25,187	US$3.4k	0%	no data
0.35%	Benjamin Partners, LLC	20,799	US$2.8k	0%	0.01%
0.29%	BNY Mellon Asset Management	17,434	US$2.4k	0%	no data
0.29%	LPL Financial Corporation, Asset Management Arm	17,404	US$2.3k	0%	no data
0.18%	Geode Capital Management, LLC	10,512	US$1.4k	-15.9%	no data
0.032%	Wells Fargo & Company, Securities and Brokerage Investments	1,915	US$258.6	0%	no data
0.026%	Brian Leuthner	1,564	US$211.1	0%	no data
0.026%	RegentAtlantic Capital, LLC	1,563	US$211.0	0%	no data
0.024%	BlackRock, Inc.	1,410	US$190.4	0.07%	no data
0.019%	Stephany Foster	1,137	US$153.5	99.8%	no data
0.017%	Robert DelAversano	1,008	US$136.1	0.9%	no data
0.0018%	James DeMesa	110	US$14.8	6.8%	no data
0.0012%	Morgan Stanley & Co. International Plc Investment Account	73	US$9.8	0%	no data
0.00077%	Advisor Group Holdings, Inc., Asset Management Arm	46	US$6.2	0%	no data
0.00023%	Wells Fargo & Company, Private Banking and Investment Banking Arm	14	US$1.9	133%	no data
0.00007%	Group One Trading LP, Asset Management Arm	4	US$0.6	-20%	no data